Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

NCT06483919 is registered in ClinicalTrials.gov with Jinming Yu as lead sponsor.

NCT NCT06483919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06483919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
Lead sponsor
Jinming Yu
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2023
Completion date
January 30, 2025
Enrollment
228 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small-cell lung cancer